Particularly in the FilC/PD-1 virus-treated group (42.8 vs. 29.7% in PD-1 inhibitor alone), flow cytometry and immunohistochemistry analysis demonstrated a notable rise in CD8 + T cell infiltration inside the tumor microenvironment. Here, CD8A is linked to neoplasm.